FDA 483 - Labcorp Early Development Laboratories, Inc. - February 17, 2014

This FDA Form 483 was issued to Covance Laboratories, Inc. in Madison, WI, following an inspection of their bioanalytical laboratory. The observations primarily highlight deficiencies in method validation, sample handling, documentation practices, and employee training records. The findings indicate issues with data integrity and adherence to established procedures for analytical studies.